2019冠状病毒病患者中的消化道出血:一项配对病例对照研究
这项配对病例对照(1:2)研究纳入41例伴消化道出血(GIB)的COVID-19患者和82例配对无GIB的COVID-19患者,比较病因、结局与治疗。结果显示上、下消化道出血最常见病因分别为胃或十二指肠溃疡(80%)和直肠管相关直肠溃疡(60%);7例需干预者均成功止血,作者认为保守管理似乎是合理的初始方法,但需更大规模研究指导管理。
要点
- 上消化道出血最常见病因为胃或十二指肠溃疡(80%),下消化道出血最常见病因为直肠管相关直肠溃疡(60%)。
- 10例(32%)上消化道出血患者接受食管胃十二指肠镜检查,5例(50%)下消化道出血患者接受乙状结肠镜或结肠镜检查。
- 接受内镜治疗与保守治疗患者的输血需求无显著差异。
核心结论
- 在伴GIB的COVID-19患者中,与配对无GIB的COVID-19患者相比,初始表现症状似乎无差异。
- 上、下消化道出血最常见病因分别为消化性溃疡病和直肠管所致直肠溃疡。
- 保守管理似乎是处理这些复杂病例的合理初始方法,但需更大规模研究指导管理。
研究设计与样本
- 配对病例对照(1:2)研究,纳入41例伴GIB的COVID-19患者(31例上消化道、10例下消化道)和82例配对无GIB的COVID-19患者。
- 主要目的为描述出血病因,次要目的为讨论结局和治疗方式。
主要发现
- 病例与对照的初始表现症状无差异,COVID-19严重程度也无差异(P > 0.05)。
- 上消化道出血最常见病因为胃或十二指肠溃疡(80%);下消化道出血最常见病因为直肠管相关直肠溃疡(60%)。
- 4例食管胃十二指肠镜检查实施了治疗性干预,3例直肠溃疡患者被转诊至结直肠外科行直肠填塞。
- 7例需干预的病例均成功止血;接受内镜治疗与保守治疗患者的输血需求无显著差异。
- 抗凝和直肠管使用有成为GIB危险因素的趋势,但未达统计学显著。
局限性
- 抗凝和直肠管使用有成为GIB危险因素的趋势,但未达统计学显著。
- 作者认为保守管理似乎是合理的初始方法,但需更大规模研究指导管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although current literature has addressed gastrointestinal presentations including nausea, vomiting, diarrhea, abnormal liver chemistries, and hyperlipasemia as possible coronavirus disease 2019 (COVID-19) manifestations, the risk and type of gastrointestinal bleeding (GIB) in this population is not well characterized. METHODS: This is a matched case-control (1:2) study with 41 cases of GIB (31 upper and 10 lower) in patients with COVID-19 and 82 matched controls of patients with COVID-19 without GIB. The primary objective was to characterize bleeding etiologies, and our secondary aim was to discuss outcomes and therapeutic approaches. RESULTS: There was no difference in the presenting symptoms of the cases and controls, and no difference in severity of COVID-19 manifestations (P > 0.05) was observed. Ten (32%) patients with upper GIB underwent esophagogastroduodenoscopy and 5 (50%) patients with lower GIBs underwent flexible sigmoidoscopy or colonoscopy. The most common upper and lower GIB etiologies were gastric or duodenal ulcers (80%) and rectal ulcers related to rectal tubes (60%), respectively. Four of the esophagogastroduodenoscopies resulted in therapeutic interventions, and the 3 patients with rectal ulcers were referred to colorectal surgery for rectal packing. Successful hemostasis was achieved in all 7 cases that required interventions. Transfusion requirements between patients who underwent endoscopic therapy and those who were conservatively managed were not significantly different. Anticoagulation and rectal tube usage trended toward being a risk factor for GIB, although it did not reach statistical significance. DISCUSSION: In COVID-19 patients with GIB, compared with matched controls of COVID-19 patients without GIB, there seemed to be no difference in initial presenting symptoms. Of those with upper and lower GIB, the most common etiology was peptic ulcer disease and rectal ulcers from rectal tubes, respectively. Conservative management seems to be a reasonable initial approach in managing these complex cases, but larger studies are needed to guide management.
引用
- Martin TA, Wan DW, Hajifathalian K, et al. Gastrointestinal Bleeding in Patients With Coronavirus Disease 2019: A Matched Case-Control Study. Am J Gastroenterol. 2020. PMID: 32796176. doi:10.14309/ajg.0000000000000805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。